CompuGroup Medical Recommends Acceptance of CVC's Delisting Offer

CompuGroup Medical SE & Co. KGaA has published a recommendation for shareholders to accept CVC Capital Partners' public delisting offer. The offer price is set at EUR 22.00 per share, deemed fair by the Managing Directors, Administrative Board, and Supervisory Board. Shareholders have until June 24, 2025, to accept the offer. Despite the outcome, CompuGroup will delist from the Frankfurt Stock Exchange.

This transition aligns with CompuGroup's strategy to enhance its investments in cloud-based software and AI technologies. The CFO, Daniela Hommel, emphasized that the delisting supports long-term growth free from market pressures. Post-delisting, trading opportunities will decrease, affecting remaining shareholders.

To participate, shareholders must contact their banks before the formal deadline. Delisting is expected before the Annual General Meeting on August 1, 2025. The complete offer details are available online.